It is well recognized that polymorphisms in folate pathway genes can modify folate levels and risk of cancers (such as colon cancer), such as dihydrofolate reductase (DHFR) and methylenetetrahydrofolate reductase (MTHFR) [23,24,25]. The gene discussed is MTHFR; the disease is cancer.